# The Severe Soft Tissue Bleeding Study

> **NCT00977925** · PHASE3 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 91 (actual)

## Conditions studied

- Soft Tissue Bleeding

## Interventions

- **BIOLOGICAL:** Fibrin Pad
- **PROCEDURE:** Standard of Care

## Key facts

- **NCT ID:** NCT00977925
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-01
- **Final completion:** 2011-03
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2015-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977925, "The Severe Soft Tissue Bleeding Study". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT00977925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*